Observational study / 2009
In 8,541 cancer patients, cachexia prevalence varied from 2.4% to 14.7% depending on the clinical definition used.
Electronic medical records were examined to estimate the proportion of patients with select cancers who developed cachexia based on four separate clinical definitions. Among 8,541 cancer patients, cachexia was identified in 2.4% using the ICD-9 cachexia code, 5.5% using expanded diagnoses, 6.4% using prescription medication records, and 14.7% using a criterion of >=5% weight loss. The authors conclude that the proportion of patients with cachexia varied considerably depending on the definition employed, highlighting the need for a standard operational definition.
Shows an association, not proof of cause and effect.
- Study type
- Retrospective cohort study
- Who was studied
- 8,541 cancer patients (60% men, 55% Caucasian) diagnosed between 1999 and 2004
- What was measured
- Proportion of cancer patients with cachexia based on four definitions
THE PAPER
Estimation of Cachexia among Cancer Patients Based on Four Definitions.
Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF. J Oncol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.